€100m expansion to create 300 new jobs in Cherrywood

by Rose Barrett
0 comment

Rose Barrett

The Medicine Acceleratorand Manufacture (VLE) this week announced a groundbreaking expansion that involves the creation of 300 new R&D jobs and a €100m capital expansion to form a globally unique Medicine Accelerator Campus in Cherrywood, Dublin. 

The Irish fully owned multinational group responsible for breakthrough pharma process research and development, APC and VLE will expand to deliver a 130,000 sq ft campus, the largest R&D site in the biopharma sector in Ireland.  

The new expanded home for APC & VLE will integrate the latest developments in scientific research, AI, neural networks and scientifically led manufacturing activities. This value chain is transforming medicine development and the time to patient for new and advanced therapeutics.

Partnering with eight of the top 10 pharmaceutical companies globally and a wide range of biotechs, APC & VLE works across a wide range of therapeutic areas. The business is currently working on 35+ medicines that transform patient treatment in areas such as oncology, respiratory disease, Alzheimer’s, HIV and more, at its HQ in Dublin. Serving as a global research epicentre The Medicine Accelerator Campus represents one of the most disruptive businesses in pharmaceutical development, digitalization and manufacturing.

At its core, this disruption will be facilitated by three interwoven strategic elements:

1.    Best-in-class Science: Advancing the boundaries of pharmaceutical process research and development through a world class team of scientific experts.

2.    First-in-class Digital: Accelerating medicine development and manufacturing outcomes through the application of our state-of-the-art digital technologies and Artificial Intelligence.

3.    Science-First Manufacturing: Driving manufacturing outcomes through industry-first scientific and digitalisation breakthroughs.

The group is already the largest national employer of R&D scientists, within the pharmaceutical sector. This addition of 300 new roles will bring the combined team to over 600 scientists, digital experts, and manufacturing professionals bringing The Medicine Accelerator team to a global stage.

Mark Barrett, CEO and Co-Founder of APC & VLE Therapeutics, says the expansion solidifies APC & VLE’s commitment to advancing innovation in the global pharmaceutical industry.

Reimagining how medicines are developed and accelerated to patients is our motivation, our purpose. As an Irish Multinational company, it also solidifies our confidence in the biopharma ecosystem in Ireland as a global hub, one that is trusted and central to medicine supply chains globally, to drive further innovation in the areas of pharmaceutical R&D, digitalization, and manufacture.

Repro Free: 10/06/2021 APC, an Irish pharmaceutical R&D company, unveils €25m investment and 120 jobs to accelerate development and manufacture of Covid Vaccines and Advanced Therapeutics APC CEO Dr. Mark Barrett is pictured as the award-winning Irish pharmaceutical research and development company announce €25M investment and creating 120 jobs through the formation of a ‘Global Centre of Excellence for Vaccine and Advanced Therapeutic Research and Manufacturing’. As a global ‘medicine accelerator’, APC’s expanded facility will enable the rapid research and manufacture of vaccines, including Covid 19 vaccines, and other advanced therapeutics for rare diseases. It will provide supply chains nationally and across Europe with these vital medicines, positioning Ireland as a significant contributor on the international stage to the manufacture of Covid vaccines and other critical Advanced Therapeutics. Picture Andres Poveda ENDS For further details, please contact: Breda Brown / Viv Murphy Unique Media Tel: (01) 5225200 / 087 2487120 (BB)

“The support of Enterprise Ireland has been pivotal in accelerating this expansion and we look forward to continuing to work with them on our mission to accelerate medicines to patients.”

Welcoming the announcement, Simon Coveney, Minister for Enterprise, Trade and Employment of Ireland, said:

”I want to congratulate Mark and his team at APC & VLE on this week’s landmark announcement.  The new Medicine Accelerator Campus demonstrates the capacity of Irish-owned businesses to become world leaders in their field, bringing together technology, innovation and ambition to make a real difference in people’s lives across the globe.

“The government through Enterprise Ireland is committed to scaling and building globally impactful Irish Multinationals that will help drive the Irish economy forward and create high value jobs at home. APC & VLE’s announcement today is testament to that Irish Multinational ambition in action and I am delighted to support them on their patient-focused mission.”

Related Articles